Clinical Trial Update: Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study) [NA]

View source ↗

Summary

A clinical trial update indicates that the Self-Expanding Coronary Sinus Reducer is being studied for symptomatic coronary microvascular dysfunction in the SERR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Disease
• Coronary Microvascular Dysfunction

Drugs mentioned

• Self Expanding Coronary Sinus Reducer

Snippet

Sponsor: VahatiCor, Inc. | Conditions: Coronary Microvascular Dysfunction, Coronary Microvascular Disease | NA | Status: RECRUITING